
Advocacy groups warn Trump's pharmaceutical tariffs will spike costs
One year after the launch of his "Liberation Day" initiative, President Donald Trump has moved to impose steep tariffs on imported pharmaceuticals and their ingredients. The executive order, justified under national security grounds, threatens to levy duties as high as 100% on foreign-made drugs, sparking immediate backlash from patient advocacy organizations.

















